Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice

Purpose: To describe the rationale and design of the VOYAGER (NCT05476926) study, which aims to investigate the safety and effectiveness of faricimab and the Port Delivery System with ranibizumab (PDS) for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) in clinica...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Robyn Guymer, MBBS, PhD, Clare Bailey, MD, FRCP, Voraporn Chaikitmongkol, MD, Usha Chakravarthy, FRCOphth, PhD, Varun Chaudhary, MD, FRCS(C), Robert P. Finger, MD, PhD, Roberto Gallego-Pinazo, MD, PhD, Adrian Koh Hock Chuan, MBBS, MMed (Ophth), Susumu Ishida, MD, PhD, Monica Lövestam-Adrian, MD, PhD, Mariacristina Parravano, MD, Jose D. Luna Pinto, MD, Steffen Schmitz-Valckenberg, MD, Veeral Sheth, MD, MBA, Eric H. Souied, MD, PhD, Gloria C. Chi, PhD, MPH, Frank Gilberg, PhD, Carl Glittenberg, MD, Stefan Scheidl, MSc, PhD, Monica Bengus, MD
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2024-05-01
Serier:	Ophthalmology Science
Fag:	Diabetic macular edema Faricimab Neovascular age-related macular degeneration Port Delivery System with ranibizumab Real-world study
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2666914523001744
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!